Compare TTEC & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEC | CSBR |
|---|---|---|
| Founded | 1982 | 1985 |
| Country | United States | United States |
| Employees | 69400 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.0M | 66.7M |
| IPO Year | 1996 | 2015 |
| Metric | TTEC | CSBR |
|---|---|---|
| Price | $1.48 | $4.88 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 283.9K | 12.5K |
| Earning Date | 11-05-2026 | 09-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,509,171,000.00 | $2,900,000.00 |
| Revenue This Year | N/A | $9.83 |
| Revenue Next Year | $0.71 | $8.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $1.18 | $4.59 |
| 52 Week High | $3.99 | $8.31 |
| Indicator | TTEC | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 46.98 |
| Support Level | $1.18 | $4.71 |
| Resistance Level | $2.49 | $6.31 |
| Average True Range (ATR) | 0.05 | 0.26 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 89.66 | 36.19 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.